Search

Focal or partial seizures are a common neurological disorder affecting adults. This review aims to provide an in-depth understanding of focal seizures in adults, including their classification, clinical presentation, etiology, diagnosis, and management. This article seeks to enhance awareness and knowledge among medical professionals and the general public by exploring the latest research and clinical insights. Standard electroencephalography (EEG) and recordings in presurgical electrode depth in humans provide a clear definition of patterns similar to focal seizures. Models of animals with partial seizures and epilepsy mimic seizure patterns with comparable characteristics. However, the network factors supporting interictal spikes, as well as the start, development, and end of seizures remain obscure. According to recent research, inhibitory networks are heavily implicated at the beginning of seizures, and extracellular potassium alterations help start and maintain seizure continuation. An increase in network synchronization, which may be caused by both excitatory and inhibitory pathways, is correlated with the cessation of a partial seizure. Recent research on temporal lobe focal seizures in human and animal models leads to the hypothesis that the active blocking of subcortical arousal processes brings on unconsciousness. Brainstem, basal forebrain, and thalamic arousal networks' neuronal firing is diminished during focal limbic seizures, and cortical arousal can be recovered when subcortical arousal circuits are engaged. These results suggest that thalamic neurostimulation may be therapeutic to restore arousal and consciousness during and after seizures. Targeted subcortical stimulation may increase arousal and consciousness when current treatments cannot halt seizures, enhancing safety and psychosocial function for epileptic patients. We embark on an investigation into adult focal seizures in this thorough review that goes beyond a cursory knowledge of their clinical symptoms., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Ghulaxe et al.)

From a broader perspective, antibiotic or antimicrobial resistance is still evolving and spreading internationally. Infectious diseases have become more complex and often impossible to cure, increasing morbidity and mortality. Despite the failure of conventional, standard antimicrobial therapy, no new class of antibiotics has been developed in the last 20 years, which results in various cutting-edge and other tactics that can be used to encounter these disease-causing microorganisms with antibiotic resistance. In the continued fight against bacterial infections, there is an urgent requirement for new antibiotics and other antimicrobials. Antibiotic resistance is inevitable, and pharmaceutical companies consistently show little interest in funding novel antibiotic research. Some methods are being used as a possible replacement for conventional antibiotics. Combination therapy, methods that target the proteins or enzymes that cause antimicrobial resistance and bacterial resistance, systems for delivery of the drug, physicochemical approaches, and informal ways, such as the CRISPR-Cas system, are some of these approaches. These various approaches influence how multi-drug-resistant organisms are handled in human clinical settings., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Chavada et al.)

Intra-body transmission networks are proposed to be composed of nanostructured or micro-sized detectors placed within the body to monitor health and distribute drugs. Transplanted biosensors are the potential options for monitoring the body for the detection of particular ailments and determining a diagnosis with the help of a doctor. Biological systems inside the body remain intricately integrated and interact primarily through biochemical interactions. Thus, the continuous communication performance and intra-body molecular nanonetworks coordinate essential functions within the human body. Spontaneous intra-body molecular nanonetworks, on the other hand, have yet to be investigated using sophisticated tools of information and communication concepts. We intend to understand the exquisite molecular networking that exists within us to design and develop pragmatic, effective interaction for evolving nanonetworks and also to lay the groundwork for the progression of groundbreaking diagnosis and therapeutic methodologies inspired by technological tools, which have the potential to be helpful in future nanotechnologies and bioinspired molecular communication (MC) applications., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2022, Sarda et al.)